some perspective, page-4

kakoii wrote;

"this side has no meaning at all"

Good grief.
Who cares what the company name was.

Are you suggesting if 'Avita Medical' were to change names, for whatever hypothetical reason, then everything AVH had acheived would also be meaningless?
What an insult to our intelligence.

Because that is exactly what you are foolishly suggesting.

The underlying point kakoii conveiently ignores, is that the product in question IS ReCell.

Either the market believes in the product.
Or they don't.

So, the question remains.
If the underlying product/technolgy is so wonderful, then why isn't the company's share price well above the $5.90 peak back when "it didn't matter".

Again.
Anyone who has bought in, in recent times, has everything to gain from ramping this up, even by a few cents.
This is not rocket science.
Potential investors should beware of the incessant ramping found with AVH discussion.

Look at where it's down from, and ask yourself, why hasn't it gotten back up there again.

Even more so, when ReCell is already approved for sale in most parts of the world, with the USA being the last region to conquer.

Most respectable companies recovered from the GFC long ago.
Look at their share price graphs.
IMO, using the GFC as an excuse, 4 years on, is a desperate excuse.

The broader market obviosuly agrees with my sentiment more than yours kakoii. Sorry, but that bitter reality.